mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-06 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0001 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |